CASI PHARMACEUTICALS

CASI Pharmaceuticals, Inc. ("CASI", "we" or "us") is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. CASI is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. CASI is executing its plan to become a biopharmaceutical leader by launching medicines in the greater China market leveraging CASI's China-based regulatory and commercial competencies and its global drug development expertise.

#SimilarOrganizations #People #Financial #Website #More

CASI PHARMACEUTICALS

Social Links:

Industry:

Biotechnology Medical Pharmaceutical

Founded:

1991-01-01

Address:

Rockville, Maryland, United States

Country:

United States

Website Url:

http://www.casipharmaceuticals.com

Total Employee:

101+

Status:

Active

Contact:

(240) 864-2643

Email Addresses:

[email protected]

Total Funding:

147.38 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Universal Analytics Nginx Euro

Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

Current Employees Featured

not_available_image

Ken Keyong Ren
Ken Keyong Ren CEO @ CASI Pharmaceuticals
CEO
2013-04-04

john-w-holaday_image

John W Holaday
John W Holaday co-founder @ CASI Pharmaceuticals
co-founder

not_available_image

Alexander A. Zukiwski
Alexander A. Zukiwski CMO @ CASI Pharmaceuticals
CMO
2017-04-01

not_available_image

James Goldschmidt
James Goldschmidt Senior Vice President of Business Development @ CASI Pharmaceuticals
Senior Vice President of Business Development
2016-04-01

elisabeth-uible_image

Elisabeth Uible
Elisabeth Uible Corporate Communications @ CASI Pharmaceuticals
Corporate Communications
2019-08-01

Founder

john-w-holaday_image

John W Holaday

Stock Details

Company's stock symbol is NASDAQ:CASI

Acquisitions List

Date	Company	Article	Price
2006-01-10	Miikana Therapeutics	Miikana Therapeutics acquired by CASI Pharmaceuticals	9.96 M USD

Investors List

robert-w-duggan_image

Investments List

Date	Company	Article	Money raised
2022-07-08	Precision Autoimmune Therapeutics	CASI Pharmaceuticals investment in Venture Round - Precision Autoimmune Therapeutics	140 M CNY
2019-07-09	Juventas	CASI Pharmaceuticals investment in Series A - Juventas	100 M CNY

Official Site Inspections

http://www.casipharmaceuticals.com Semrush global rank: 1.53 M Semrush visits lastest month: 17.33 K

Host Informations
Whois Informations

Loading ...